RetroSense Therapeutics' Seed VC Round

RetroSense Therapeutics raised a round of funding on July 20, 2011. Investors include Michigan Pre-Seed Capital Fund.

RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (…

Articles about RetroSense Therapeutics' Seed VC Round: